Registry of patients treated for venous thromboembolism
Official title: Russian Registry of Treatment of Venous Thromboembolism
Run by Medalp Private Surgery Clinic · NCT03881345 · Data updated 2026-11-12
This study is tracking patients with blood clots to see how different treatments work and to help with future research.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Medalp Private Surgery Clinic Academic / other |
| Locations | 1 site (Moscow, Moscow) |
| Status | Recruiting |
| Started | April 1, 2019 |
| Main results expected | March 1, 2036 |
| Study ends | March 1, 2036 |
| Registry record updated | May 8, 2025 |
| Trial ID | NCT03881345 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with venous thrombosis of a limb or pulmonary embolism.
✕Probably not a fit
Patients who do not have venous thrombosis or pulmonary embolism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves the ongoing registration of patients diagnosed with venous thromboembolism (VTE) who are treated using various methods such as antithrombotic therapy, thrombolysis, open surgery, and venous stenting. Data from patients across multiple medical centers in Russia are collected and entered into a prospective digital database, which is continuously updated. The study aims to facilitate future prospective randomized, cohort, and observational studies based on the collected data.
Why it matters
Potential benefit: If successful, this registry could improve treatment strategies and outcomes for patients with venous thromboembolism.
How similar studies have gone: Other studies have shown success with similar registries and observational approaches in managing venous thromboembolism.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * case of venous thrombosis of a limb or pulmonary embolus Exclusion Criteria: * no exclusion criteria
Where it's running
-
Pirogov Russian National Research Medical University
Moscow, Moscow, Russia Recruiting
Study contacts
- Study coordinator: Evgeny Ilyukhin
- Email: evgeny@ilyukhin.info
- Phone: +79218451722
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization
This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.
-
Timing of anticoagulation for preventing blood clots in patients with brain hemorrhage
This study is testing whether starting blood-thinning treatment early or later can help prevent blood clots in patients with bleeding in the brain while keeping them safe from more bleeding.
-
Observational study of blood clotting and bleeding disorders in Chinese patients
This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.
-
Personalized blood thinner treatment for hip and knee replacement patients
This study is testing if personalized blood thinner treatments can better prevent blood clots and bleeding in patients getting hip or knee replacements compared to standard treatments.
-
Evaluating a new decision support tool for diagnosing blood clots
This study is testing a new tool to help doctors diagnose blood clots in patients who might have conditions like pulmonary embolism or deep vein thrombosis, using fresh blood samples.
-
Cancer-associated VTE: A follow-up study collecting biological samples
This study tests how often cancer patients who have had a VTE will experience more clots over time and gathers blood and urine samples to explore why it happens.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.